Cambridge Financial Group Inc. Grows Stake in Walgreens Boots Alliance Inc (NASDAQ:WBA)

Cambridge Financial Group Inc. grew its holdings in Walgreens Boots Alliance Inc (NASDAQ:WBA) by 7.6% during the first quarter, according to the company in its most recent filing with the SEC. The fund owned 99,867 shares of the pharmacy operator’s stock after acquiring an additional 7,070 shares during the quarter. Walgreens Boots Alliance comprises 3.1% of Cambridge Financial Group Inc.’s investment portfolio, making the stock its 23rd biggest holding. Cambridge Financial Group Inc.’s holdings in Walgreens Boots Alliance were worth $4,569,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Caisse DE Depot ET Placement DU Quebec boosted its position in shares of Walgreens Boots Alliance by 1.8% in the 4th quarter. Caisse DE Depot ET Placement DU Quebec now owns 14,484,065 shares of the pharmacy operator’s stock valued at $853,980,000 after purchasing an additional 257,400 shares during the period. Geode Capital Management LLC boosted its position in shares of Walgreens Boots Alliance by 1.9% in the 4th quarter. Geode Capital Management LLC now owns 11,207,142 shares of the pharmacy operator’s stock valued at $659,354,000 after purchasing an additional 205,271 shares during the period. Norges Bank acquired a new stake in shares of Walgreens Boots Alliance in the 4th quarter valued at about $492,928,000. American International Group Inc. boosted its position in shares of Walgreens Boots Alliance by 781.9% in the 4th quarter. American International Group Inc. now owns 5,511,875 shares of the pharmacy operator’s stock valued at $324,980,000 after purchasing an additional 4,886,896 shares during the period. Finally, Charles Schwab Investment Management Inc. boosted its position in shares of Walgreens Boots Alliance by 3.5% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 3,959,827 shares of the pharmacy operator’s stock valued at $233,472,000 after purchasing an additional 134,674 shares during the period. Institutional investors and hedge funds own 58.03% of the company’s stock.

A number of analysts recently issued reports on the company. ValuEngine cut Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a research report on Tuesday, March 3rd. BidaskClub cut Walgreens Boots Alliance from a “sell” rating to a “strong sell” rating in a research report on Friday, May 15th. Deutsche Bank raised Walgreens Boots Alliance from a “sell” rating to a “hold” rating and decreased their price objective for the stock from $51.00 to $43.00 in a research report on Friday, April 3rd. Wells Fargo & Co reaffirmed a “hold” rating on shares of Walgreens Boots Alliance in a research report on Thursday, April 2nd. Finally, JPMorgan Chase & Co. decreased their price objective on Walgreens Boots Alliance from $62.00 to $56.00 and set a “neutral” rating for the company in a research report on Friday, April 3rd. Four analysts have rated the stock with a sell rating and thirteen have given a hold rating to the company’s stock. Walgreens Boots Alliance currently has an average rating of “Hold” and an average price target of $51.21.

Shares of WBA stock traded down $0.15 during trading hours on Friday, reaching $39.60. 3,378,765 shares of the company’s stock were exchanged, compared to its average volume of 7,383,946. The company has a market cap of $34.87 billion, a P/E ratio of 6.87, a price-to-earnings-growth ratio of 1.83 and a beta of 0.55. The company’s 50 day moving average is $42.22 and its two-hundred day moving average is $51.33. Walgreens Boots Alliance Inc has a 1 year low of $36.65 and a 1 year high of $64.50. The company has a debt-to-equity ratio of 1.34, a current ratio of 0.66 and a quick ratio of 0.32.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its earnings results on Thursday, April 2nd. The pharmacy operator reported $1.52 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.46 by $0.06. The business had revenue of $35.82 billion during the quarter, compared to the consensus estimate of $35.24 billion. Walgreens Boots Alliance had a return on equity of 21.26% and a net margin of 2.52%. The company’s revenue for the quarter was up 3.7% on a year-over-year basis. During the same period in the prior year, the business posted $1.64 EPS. As a group, analysts predict that Walgreens Boots Alliance Inc will post 5.53 EPS for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, June 12th. Investors of record on Wednesday, May 20th will be paid a $0.4575 dividend. This represents a $1.83 annualized dividend and a yield of 4.62%. The ex-dividend date of this dividend is Tuesday, May 19th. Walgreens Boots Alliance’s payout ratio is currently 30.55%.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.

Recommended Story: What are the Different Types of Leveraged Buyouts?

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.